BIOMARKER:

RAD54L mutation

Entrez ID:

Related biomarkers:

‹

›

RAD54L mutation RAD54L mutation	Prostate Cancer Prostate Cancer	olaparib Sensitive: A2 - Guideline
RAD54L mutation RAD54L mutation	Small Cell Lung Cancer Small Cell Lung Cancer	olaparib Sensitive: C2 – Inclusion Criteria
RAD54L mutation RAD54L mutation	HER2 Negative Breast Cancer HER2 Negative Breast Cancer	durvalumab Sensitive: C2 – Inclusion Criteria

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

Associations